Some of the earlier reports on ERAD during NAFLD focused on Apolipoprotein B (ApoB) (Fisher et al., 1997; Gusarova et al., 2001; Hrizo et al., 2007; Brodsky and Fisher, 2008). The gene discussed is APOB; the disease is metabolic dysfunction-associated steatotic liver disease.